Shenzhen Neptunus Bioengineering Co Ltd

SHE:000078 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.17 Billion
CN¥8.55 Billion CNY
Market Cap Rank
#9286 Global
#1886 in China
Share Price
CN¥3.25
Change (1 day)
-1.22%
52-Week Range
CN¥2.22 - CN¥5.29
All Time High
CN¥9.81
About

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines, infusion products, and western medicine preparations in China. The company provides oryzanol tablets, chlorpheniramine maleate tablets, estazolam tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and othe… Read more

Shenzhen Neptunus Bioengineering Co Ltd (000078) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.006x

Based on the latest financial reports, Shenzhen Neptunus Bioengineering Co Ltd (000078) has a cash flow conversion efficiency ratio of -0.006x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-16.37 Million) by net assets (CN¥2.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shenzhen Neptunus Bioengineering Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Shenzhen Neptunus Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Shenzhen Neptunus Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Neptunus Bioengineering Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Shenzhen Neptunus Bioengineering Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen Neptunus Bioengineering Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.84 Billion CN¥39.54 Million 0.014x +114.30%
2023-12-31 CN¥4.22 Billion CN¥-410.19 Million -0.097x -823.85%
2022-12-31 CN¥6.11 Billion CN¥-64.33 Million -0.011x -108.88%
2021-12-31 CN¥7.31 Billion CN¥866.12 Million 0.119x -46.22%
2020-12-31 CN¥7.49 Billion CN¥1.65 Billion 0.220x -23.74%
2019-12-31 CN¥7.85 Billion CN¥2.27 Billion 0.289x +282.22%
2018-12-31 CN¥7.16 Billion CN¥-1.14 Billion -0.159x +57.83%
2017-12-31 CN¥6.47 Billion CN¥-2.43 Billion -0.376x -47.65%
2016-12-31 CN¥5.88 Billion CN¥-1.50 Billion -0.255x -703.04%
2015-12-31 CN¥2.14 Billion CN¥90.51 Million 0.042x +164.08%
2014-12-31 CN¥1.78 Billion CN¥-117.48 Million -0.066x -1.10%
2013-12-31 CN¥1.89 Billion CN¥-123.07 Million -0.065x +15.69%
2012-12-31 CN¥1.06 Billion CN¥-81.73 Million -0.077x +60.55%
2011-12-31 CN¥971.04 Million CN¥-190.33 Million -0.196x -531.98%
2010-12-31 CN¥902.62 Million CN¥40.96 Million 0.045x -84.77%
2009-12-31 CN¥692.59 Million CN¥206.34 Million 0.298x +13.26%
2008-12-31 CN¥780.79 Million CN¥205.39 Million 0.263x +369.89%
2007-12-31 CN¥903.62 Million CN¥50.59 Million 0.056x -10.00%
2006-12-31 CN¥868.76 Million CN¥54.04 Million 0.062x +39.82%
2005-12-31 CN¥805.26 Million CN¥35.82 Million 0.044x +205.31%
2004-12-31 CN¥1.45 Billion CN¥-61.34 Million -0.042x -114.41%
2003-12-31 CN¥1.44 Billion CN¥-28.44 Million -0.020x +63.65%
2002-12-31 CN¥2.06 Billion CN¥-111.83 Million -0.054x -29.21%
2001-12-31 CN¥1.97 Billion CN¥-82.84 Million -0.042x +90.83%
2000-12-31 CN¥238.75 Million CN¥-109.25 Million -0.458x -367.67%
1999-12-31 CN¥205.69 Million CN¥-20.13 Million -0.098x +54.56%
1998-12-31 CN¥177.08 Million CN¥-38.13 Million -0.215x --